Skip to content
10-Q

Quarterly Report

Icagen, Inc.

0001213900-18-016174

← back to feed
Filed
Nov 19, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2018 · Nov 16, 2018 6.39M sh
Long Term Debt Q3 2018 · Sep 30, 2018 $12.59M
Current Liabilities Q3 2018 · Sep 30, 2018 $6.94M
Current Liabilities Q3 2018 · Dec 31, 2017 $4.97M
Total Liabilities Q3 2018 · Sep 30, 2018 $31.09M
Total Liabilities Q3 2018 · Dec 31, 2017 $23.31M
Current Assets Q3 2018 · Sep 30, 2018 $5.12M
Current Assets Q3 2018 · Dec 31, 2017 $4.79M
Total Assets Q3 2018 · Sep 30, 2018 $14.32M
Total Assets Q3 2018 · Dec 31, 2017 $14.64M
Rd Expense Q3 2018 · Sep 30, 2018 $696.82K
Rd Expense Q3 2018 · Sep 30, 2018 $925.53K
Rd Expense Q3 2018 · Sep 30, 2017 $2.23M
Rd Expense Q3 2018 · Sep 30, 2017 $2.41M
Capex Q3 2018 · Sep 30, 2017 $791.16K
Operating Cash Flow Q3 2018 · Sep 30, 2017 −$7.34M
Cash And Equivalents Q3 2018 · Sep 30, 2017 $6.03M
Cash And Equivalents Q3 2018 · Jun 30, 2017 $5.8M
Cash And Equivalents Q3 2018 · Dec 31, 2016 $4.94M
Sga Expense Q3 2018 · Sep 30, 2017 $3.45M
Sga Expense Q3 2018 · Sep 30, 2017 $10.36M
Net Income Q3 2018 · Sep 30, 2017 −$1.73M
Net Income Q3 2018 · Sep 30, 2017 −$4.45M
Operating Income Q3 2018 · Sep 30, 2017 −$1.2M
Operating Income Q3 2018 · Sep 30, 2017 −$3.5M
Gross Profit Q3 2018 · Sep 30, 2017 $2.67M
Gross Profit Q3 2018 · Sep 30, 2017 $8.24M
Revenue Q3 2018 · Sep 30, 2017 $5.42M
Revenue Q3 2018 · Sep 30, 2017 $17.02M